Prescription or Poison: The Effects of Direct to Consumer Advertising
New Zealand and the U.S are the only two countries in the world where Direct to Consumer (DTC) of prescription is legal. DTC of drugs means the commercials listing of potential problems and then suggesting a pill as a solution. These commercials often advertise drugs that are not FDA approved, as they are not required to. Drug manufacturing companies, not the doctors, put out these advertisements in media. These DTC ads used to have to go through doctors to get sold, but now they use DTCA to sell their products, therefore are not required to inform the consumer about all risks.
In 2015, at solely retail pharmacies, over 4,065,000,000 prescriptions were filled within a year. DTCA of drugs is a controversial issue that is addressed around the world and affects countless families whom have family members that have faced repercussions of DTCA. The U.S
…show more content…
According to Dr. Stange and the U.S. Library of Medicine, “58% strongly agree that DTC ads make the drugs seem much better than they are”. (https://www.ncbi.nlm.nih.gov) This DTCA is a pipedream for people. The economy is extremely altered by the expensive drugs being advertised. According to the International Society for Pharmacoeconomic and Outcomes Research, “DTCA may also increase the utilization and health care costs by only focusing on the newest and most expensive drugs”. (https://www.ispor.org) Thus, the squabble of society is sustained. Nearly 70% of Americans are on at least one prescribed drug, the over utilization of this is becoming more apparent. Dr. Matthews of the Mackinac Center states that, “giving away samples lures patients into using prescription drugs.” (https://www.mackinac.org/) Which shows how the companies weigh the sales of their products to the help of the
The prices of prescription drugs in the United States are by far the highest in the world. [1] On average, Europeans pay 40% less than Americans for the same medications. [2] Consumers have been resorting to several ways, sometimes putting themselves in harm’s way, to alleviate the burden of high prescription drug costs. Some buy their medications online or cross the borders to neighboring countries so they would be able to afford buying their needed medications. Others have resorted to the illegal act of selling their unused medications in online forums just to recover part of their expenses. Many factors contribute to the increased drug prices in the United States including research and
Despite this, the industry did not alter its ways, maintaining that its ad campaigns were "educational," and that people were able to make their own decisions about what they purchased (Payer 66). However, it is evident that the advertisements produced by the pharmaceutical industry are designed for the very purpose of making it difficult for people to make these decisions independently. This marketing produces a large number of often deceptive, misleading tactics which have a large influence on both consumers and medical practitioners. The chief beneficiaries of this marketing are not the consumers but the pharmaceutical companies themselves.
The rise in costs of prescription medicines affects all sectors of the health care industry, including private insurers, public programs, and patients. Spending on prescription drugs continues to be an important health care concern, particularly in light of rising pharmaceutical costs, the aging population, and increased use of costly specialty drugs. In recent history, increases in prescription drug costs have outpaced other categories of health care spending, rising rapidly throughout the latter half of the 1990s and early 2000s. (Kaiseredu.org, 2012).
A new escalating drug abuse epidemic has come about in the recent years; people are now choosing prescription pills as their new drug of choice. The use, abuse and death caused by prescription drugs has increased significantly within the past couple years. All types of prescription pills are more easily accessible from their doctors, family members or off the street. Doctors are handing out prescriptions for pills, such as pain management pills, muscle relaxers, and anti-anxiety, like they are candy and not potentially dangerous to the consumers. In today’s society doctors are over prescribing pills to Americans and the prescription pill distribution should be more closely monitored and controlled. Although there are people who benefit
In 2015, the pharmaceutical industry spent over 27 billion dollars on advertising. The two greatest components of this effort were promotional advertising and free medication sampling, which the pharmaceuticals invested 15.5 and 5.7 billion dollars respectively (“Persuading the Prescribers”). Promotional advertising involves direct contact with health professionals, the most common being extravagant lunch conferences held for physicians and their staff. On the other hand, sampling involves distributing free sample of medications to physicians, who then have a choice of providing these samples to patients. As a result of these methods, the industry has seen revenue around $400 billion with 90% of physicians having a relationship with a drug company (Campbell 2007). Moreover, the prices of prescriptions continue to rise; a copay of a generic drug is $11.72, preferred brand drug is $36.37 and a specialty drug is $58.37 (Coleman and Geneson 2014). Although the profits are immense in the numbers demonstrated above, it is no surprise when pharmaceutical drug companies elevate their prices even more. For instance, recently Turing Pharmaceuticals raised the price of their medication Daraprim from $13.50 to $750. Keep in mind, this medication is used for threatening parasitic infections, aids, and cancer with alternative options currently found to be inefficient (Pollack 2015). Another example of this practice involves cycloserine, a drug used to
There are many direct to consumer advertising for prescription drugs. On television, magazines, radio etc, you see the most recent advertisements for prescription drugs. After some people see the advertisements they soon rush over to their doctor and their illness and life would be perfectly pain and stress free. Making the public conscious of options for treatment is not a bad thing. But these false advertisements are misleading consumers onto unnecessary treatment.
There are proponents of DTC prescription drug ads. They argue that “the ads inform patients about diseases and possible treatments, encourage people to seek medical advice, help remove stigma associated with medical conditions, and provide needed sales revenue to fund costly research and development (R&D) of new drugs (Drug Ads ProCon.org).” On the flip side opponents argue “that DTC drug ads misinform patients, promote drugs before long-term safety-profiles can be known, medicalize and stigmatize normal conditions and bodily functions like wrinkles and low testosterone, waste valuable medical appointment time, and have led to our society’s overuse of prescription drugs (Drug Ads ProCon.org).”
Proposal: Prescription drug prices are astronomically high due in part because of counterfeit drugs and because of the cost to keep them out of the country. It is not only unfortunate that it takes on average 17-18 years for a drug patent to expire, before a generic more affordable drug can substitute the brand name medications, but lives depend on getting the right affordable prescription drugs daily. Combine that with counterfeit drugs and the Food and Drug Administration (FDA) have a very large and expensive problem on its hands. Can they provide safe and effective medicines to all individuals and what will that cost? As FDA, former commissioner Mark McClellan states “we are facing a global crisis” concerning providing
Annually, the US spends $300 billion dollars on pharmaceutical drugs. This is due to the over-diagnosing of certain conditions. Everyday, Americans are exposed to an enormous amount of advertisements for medications of all kinds. For example, 1 in 10 Americans are taking
We in America tend to take medications for almost any problem we have, from headaches to gastrointestinal pain, to more serious chronic disorders such as depression and attention deficit disorder. While many of the uses of such medications may be necessary and legitimate, many are not, and due to this fact, many people become dependent on medications, mentally, and or physically. This problem is not simply the fault of the individual; in fact, the blame can also be placed upon the medical community, and the pharmaceutical companies who produce the drugs. How often can one turn on the television to see advertisements for Claritin, Aspirin, Pepto-Bismol, or even Zoloft or Ritalin? The pharmaceutical industry is motivated by monetary
The earliest human records attest to the fact that human beings have been using addictive narcotics since we were hunter-gatherers. In the eighteenth and nineteenth centuries, physicians prescribed drugs like opium, morphine, cocaine and even heroin in the United States. (Crocq 355) Currently, these substances are either highly regulated or they are outright illegal. The irony here is that the the largest pharmaceutical companies or Big Pharma as they are better known, are selling the general public narcotics that are just as addictive and harmful as what the many gangs in the United States are selling to their customer base. The last statement may sound extreme, however, the third leading cause of death after heart disease and cancer are prescription drugs both in the United States and in Europe. (Gotzche 628) Unfortunately, these pharmaceutical companies are not satisfied with just making us addicts, they are also bankrupting the American consumer and our health care system. The statistics of deaths and the criminal practices of these pharmaceutical companies are distressing, however, it is not surprising since their main objective is to maximize profits. First, let us take a look at some of the offenders.
That these ads empower the patient with interpersonal communication with their caretaker, who in turn makes the patient feel vested because they become partakers in the decision-making process of their desired treatment. The researchers suggest that due to a more engaged patient and an established relationship between the patients and doctor that these patients are described to be better off healthwise. The same study showed that out of the 329 surveyed, more than half were taking an advertised prescription medication. The authors of this study suggest that additional government oversight can improve the DTCA educational
Recently, there has been a debate about the high prescription drug prices in the United States. Accounting for 9.7% of the national health expenditure, $329.2 billion was spent on prescription medications ($931 per person) in 2011 (Linton, 2014). So what exactly is the average American getting with their $931? Well, because there is an extraordinary amount of time, effort, and energy that goes into creating, manufacturing, and distributing a new drug, it’s no wonder the prices are so high. But what other costs are folded into the prices of your prescribed medications? This review looks beyond just the research and development costs needed to take a new drug from idea to shelf by examining several journals and other credible, secondary sources, to shed some light on how much pharmaceutical companies are spending to develop, advertise, and sell their drugs.
Ads for pharmaceutical drugs are everywhere. They are in magazines, on television and radio, on billboards, and on the little bags that you get from the pharmacist. These days it is difficult to get away from all the drug advertising. All these ads are for products that require a doctor's prescription. The goal of advertising is to increase profits. By advertising so heavily for drugs that the majority of the population does not need, pharmaceutical companies attempt to create as large a consumer base as they can. In advertising directly to the consumer, the drug companies accomplish two objectives. First, they get information directly to the consumer. Second, they promote the product and
In Canada, DTCA is regulated by Health Canada. According to Canada’s Food and Drugs Act, an advertisement cannot “make any representation other than with respect to the brand name, proper name, common name, price and quantity of the drug” (Bélisle-Pipon 259). Advertising Standards Canada regulates DTCI by ensuring that “no element can directly or indirectly promote the sale of a drug” (Bélisle-Pipon 260). Consumer health materials that follow Health Canada’s Guidelines are automatically classified as DTCI and if the material does not comply, they are classified as DTCA’s. Canada’s DTCI campaigns raise similar ethical concerns as those associated with the United States’ DTCA. Canadian DTCI regulations require the suppression of drug sponsorship (Bélisle-Pipon 260). This hides the commercial marketing aspect of DTCI and thus the motivations behind the message. Transparency of a sponsor’s